SCM
TARA icon

Superstring Capital Management’s Protara Therapeutics TARA Stock Holding History

Superstring Capital Management’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$464K Hold
121,457
– – 0.29% 28
2026
Q1 		$633K Sell
121,457
-238,543
-66% -$1.41M 0.45% 32
2025
Q4 		$1.92M Hold
360,000
– – 1.03% 28
2025
Q3 		$1.57M Hold
360,000
– – 1.54% 24
2025
Q2 		$1.09M Hold
360,000
– – 1.29% 24
2025
Q1 		$1.53M Hold
360,000
– – 1.82% 17
2024
Q4 		$1.9M Buy
+360,000
New +$1.16M 1.65% 17

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Superstring Capital Management's TARA Position: Q2 2026 in Review

Superstring Capital Management held its Protara Therapeutics (TARA) position steady in Q2 2026 at 121,457 shares worth $464K. The position accounts for 0.29% of the portfolio, ranked #28.

Superstring Capital Management first reported a position in TARA in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.92M in Q4 2025. 120 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Superstring Capital Management held 121,457 shares of Protara Therapeutics worth $464K as of Q2 2026.
  • Superstring Capital Management left its Protara Therapeutics share count unchanged in Q2 2026.
  • Protara Therapeutics made up 0.29% of Superstring Capital Management's portfolio in Q2 2026, its #28 holding.
  • Superstring Capital Management first reported a position in Protara Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Superstring Capital Management's Protara Therapeutics position peaked at $1.92M in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Superstring Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.